Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries-Reference-Cited by-同舟云学术

Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries

Published:2017-10-17 Issue:suppl_9 Volume:216 Page:S838-S842
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Siberry George K¹,Amzel Anouk²,Ramos Artur³,Rivadeneira Emilia D⁴

Affiliation:

1. Office of the US Global AIDS Coordinator, US Department of State

2. Prevention Care and Treatment Division, Office of HIV/AIDS, Global Health Bureau, US Agency for International Development

3. International Laboratory Branch

4. Maternal and Child Health Branch, Division of Global HIV/TB, Center for Global Health, Centers for Disease Control and Prevention

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Centers for Disease Control and Prevention

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/216/suppl_9/S838/24264770/jix407.pdf

Reference37 articles.

1. Drug resistance among newly diagnosed HIV-infected children in the era of more efficacious antiretroviral prophylaxis;Kuhn;AIDS,2014

2. Prevalence and dynamics of the K65R drug resistance mutation in HIV-1–infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk;Inzaule;J Antimicrob Chemother,2016

3. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis;Zeh;PLoS Med,2011

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emergence of HIV-1 drug resistance mutations among children and adolescents undergoing prolonged antiretroviral therapy in Guangxi;Journal of Global Antimicrobial Resistance;2024-06

2. Disparities in access to Dolutegravir in West African children, adolescents and young adults aged 0-24 years living with HIV. A IeDEA Pediatric West African cohort analysis;2024-05-25

3. HIV Drug Resistance in Children and Adolescents: Always a Challenge?;Current Epidemiology Reports;2021-03-18

4. OUP accepted manuscript;Journal of Antimicrobial Chemotherapy;2021

5. Outcomes of protease inhibitor-based antiretroviral therapy amongst children and associated-factors in Yaoundé, Cameroon;PLOS ONE;2019-03-18